mTOR signalling pathway in stem cell bioactivities and angiogenesis potential

Hamid Lotfimehr1,2, Narges Mardi3, Samaneh Narimani2

  • 1Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Cell Proliferation
|May 8, 2023
PubMed

Insights

The mammalian target of rapamycin (mTOR) pathway regulates stem cell bioactivity and regenerative potential. Modulating mTOR signaling can effectively control stem cell-driven angiogenesis in various conditions.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Regenerative Medicine

Background:

  • The mammalian target of rapamycin (mTOR) is a crucial protein kinase responding to diverse stimuli like stress and starvation.
  • mTOR signaling influences fundamental cellular processes including growth, proliferation, and metabolism.
  • Its pleiotropic effects suggest a role in regulating various cell lineages.

Purpose of the Study:

  • To investigate the hypothesis that mTOR regulates stem cell bioactivity in response to external stimuli.
  • To highlight the relationship between the mTOR signaling axis and stem cell regenerative potential.
  • To explore mTOR's role in stem cell functions under physiological and pathological conditions.

Main Methods:

  • Systematic literature review of publications on mTOR and stem cells.
  • Searched the PubMed database from inception to February 2023.
  • Analysis of existing research on mTOR's impact on stem cell bioactivities.

Main Results:

  • The mTOR signaling cascade significantly impacts various stem cell bioactivities.
  • Angiogenesis is a key stem cell function notably affected by mTOR signaling.
  • This effect is observed in both physiological and pathological contexts.

Conclusions:

  • The mTOR pathway is a critical regulator of stem cell bioactivity and regenerative capacity.
  • Targeting mTOR signaling presents a viable strategy for modulating stem cell-driven angiogenesis.
  • Understanding mTOR's role is essential for harnessing stem cells in regenerative medicine.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K